Century Therapeutics (IPSC) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.50, +8.70% vs the prior close of $1.38.
- Volume 927.20K shares, 1.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IPSC jumps 8.7% to $1.50. Closed at $1.50, +8.70% vs the prior close of $1.38. Day range $1.36–$1.52, opened at $1.38.
IPSC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — IPSC jumps 8.7% to $1.50
- Closed at $1.50, +8.70% vs the prior close of $1.38. Day range $1.36–$1.52, opened at $1.38.
- Volume was 927.20K shares, 1.6x its 50-day average of 586.85K.
- Price is -18.7% vs its 50-day average ($1.84) and -28.4% vs its 200-day average ($2.09).
- 52-week range $0.44–$3.04; today's close sits at 41% of that range, 50.7% below the 52-week high.
Oct 14, 2026 — IPSC ends flat (+0.0%) to $1.38 on 2.2x normal volume
- Closed at $1.38, +0.00% vs the prior close of $1.38. Day range $1.31–$1.44, opened at $1.36.
- Volume was 1.27M shares, 2.2x its 50-day average of 578.41K — unusually heavy trading.
- Price is -25.6% vs its 50-day average ($1.85) and -34.0% vs its 200-day average ($2.09).
- 52-week range $0.44–$3.04; today's close sits at 36% of that range, 54.6% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — IPSC slides 4.2% to $1.38
- Closed at $1.38, -4.17% vs the prior close of $1.44. Day range $1.35–$1.44, opened at $1.44.
- Volume was 544.20K shares, 0.9x its 50-day average of 578.97K.
- Price is -26.1% vs its 50-day average ($1.87) and -34.0% vs its 200-day average ($2.09).
- 52-week range $0.44–$3.04; today's close sits at 36% of that range, 54.6% below the 52-week high.
Oct 12, 2026 — IPSC dips 2.0% to $1.44
- Closed at $1.44, -2.04% vs the prior close of $1.47. Day range $1.44–$1.51, opened at $1.47.
- Volume was 390.90K shares, 0.7x its 50-day average of 580.11K.
- Price is -23.3% vs its 50-day average ($1.88) and -31.0% vs its 200-day average ($2.09).
- 52-week range $0.44–$3.04; today's close sits at 39% of that range, 52.6% below the 52-week high.
Oct 9, 2026 — IPSC rises 0.7% to $1.47
- Closed at $1.47, +0.68% vs the prior close of $1.46. Day range $1.42–$1.55, opened at $1.46.
- Volume was 816.80K shares, 1.4x its 50-day average of 575.20K.
- Price is -22.2% vs its 50-day average ($1.89) and -29.5% vs its 200-day average ($2.09).
- 52-week range $0.44–$3.04; today's close sits at 40% of that range, 51.6% below the 52-week high.
Oct 8, 2026 — IPSC jumps 14.1% to $1.46 on 2.7x normal volume
- Closed at $1.46, +14.06% vs the prior close of $1.28. Day range $1.22–$1.46, opened at $1.26.
- Volume was 1.52M shares, 2.7x its 50-day average of 565.94K — unusually heavy trading.
- Price is -23.3% vs its 50-day average ($1.90) and -29.9% vs its 200-day average ($2.08).
- 52-week range $0.44–$3.04; today's close sits at 39% of that range, 52.0% below the 52-week high.
Oct 7, 2026 — IPSC slides 3.0% to $1.28, a 6-month low, 5 down days in a row
- Closed at $1.28, -3.03% vs the prior close of $1.32. Day range $1.27–$1.32, opened at $1.29.
- Volume was 697.20K shares, 1.2x its 50-day average of 569.15K.
- Price is -33.2% vs its 50-day average ($1.92) and -38.5% vs its 200-day average ($2.08).
- 52-week range $0.44–$3.04; today's close sits at 32% of that range, 57.9% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — IPSC slides 10.8% to $1.32, a 6-month low on 5.2x normal volume
- Closed at $1.32, -10.81% vs the prior close of $1.48. Day range $1.29–$1.50, opened at $1.48.
- Volume was 2.71M shares, 5.2x its 50-day average of 524.80K — unusually heavy trading.
- Price is -31.6% vs its 50-day average ($1.93) and -36.5% vs its 200-day average ($2.08).
- 52-week range $0.44–$3.04; today's close sits at 34% of that range, 56.6% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — IPSC slides 3.3% to $1.48, a 6-month low, 3 down days in a row
- Closed at $1.48, -3.27% vs the prior close of $1.53. Day range $1.46–$1.59, opened at $1.58.
- Volume was 771.30K shares, 1.5x its 50-day average of 522.95K.
- Price is -24.0% vs its 50-day average ($1.95) and -28.7% vs its 200-day average ($2.07).
- 52-week range $0.44–$3.04; today's close sits at 40% of that range, 51.3% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — IPSC slides 5.0% to $1.53, a 6-month low
- Closed at $1.53, -4.97% vs the prior close of $1.61. Day range $1.47–$1.67, opened at $1.64.
- Volume was 803.00K shares, 1.6x its 50-day average of 517.29K.
- Price is -21.9% vs its 50-day average ($1.96) and -26.1% vs its 200-day average ($2.07).
- 52-week range $0.44–$3.04; today's close sits at 42% of that range, 49.7% below the 52-week high.
- SEC filings that day: 8-K.
IPSC latest news & SEC filings
Every SEC filing by or about IPSC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Russotti Gregory sold 2,587 shares at $1.93 (≈$4.99K) on Sep 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Carr Douglas sold 1,658 shares at $1.93 (≈$3.20K) on Sep 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 14, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 14, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$34.55M (prior year -$32.54M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.17 (prior year -$0.38) (loss narrowed vs Jun 30, 2025)
Things to know before you trade IPSC
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 12, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.91% (largest 14.1%). That is a volatile stock.
- Liquidity: about 808.88K shares (≈$1.21M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.50 vs a range of $0.44–$3.04 (41% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 3 open-market buys, 20 sales; latest: Douglas Carr sold 1,658 shares on Sep 14, 2026.
- Latest filings: 8-K Oct 2, 2026; 8-K Sep 9, 2026; 8-K Aug 12, 2026.
- Share count: 181.08M shares outstanding (Aug 3, 2026), +109.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
IPSC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.38 | 1.52 | 1.36 | 1.50 | 927.20K |
| Oct 14, 2026 | 1.36 | 1.44 | 1.31 | 1.38 | 1.27M |
| Oct 13, 2026 | 1.44 | 1.44 | 1.35 | 1.38 | 544.20K |
| Oct 12, 2026 | 1.47 | 1.51 | 1.44 | 1.44 | 390.90K |
| Oct 9, 2026 | 1.46 | 1.55 | 1.42 | 1.47 | 816.80K |
| Oct 8, 2026 | 1.26 | 1.46 | 1.22 | 1.46 | 1.52M |
| Oct 7, 2026 | 1.29 | 1.32 | 1.27 | 1.28 | 697.20K |
| Oct 6, 2026 | 1.48 | 1.50 | 1.29 | 1.32 | 2.71M |
| Oct 5, 2026 | 1.58 | 1.59 | 1.46 | 1.48 | 771.30K |
| Oct 2, 2026 | 1.64 | 1.67 | 1.47 | 1.53 | 803.00K |
| Oct 1, 2026 | 1.65 | 1.70 | 1.60 | 1.61 | 619.40K |
| Sep 30, 2026 | 1.67 | 1.72 | 1.66 | 1.71 | 623.70K |
| Sep 29, 2026 | 1.66 | 1.67 | 1.63 | 1.65 | 353.50K |
| Sep 28, 2026 | 1.66 | 1.72 | 1.62 | 1.67 | 409.00K |
| Sep 25, 2026 | 1.70 | 1.78 | 1.63 | 1.67 | 457.00K |
| Sep 24, 2026 | 1.77 | 1.77 | 1.68 | 1.69 | 545.20K |
| Sep 23, 2026 | 1.89 | 1.94 | 1.76 | 1.76 | 508.10K |
| Sep 22, 2026 | 1.88 | 1.94 | 1.85 | 1.89 | 414.10K |
| Sep 21, 2026 | 1.87 | 1.90 | 1.83 | 1.85 | 421.00K |
| Sep 18, 2026 | 1.88 | 1.88 | 1.82 | 1.86 | 1.37M |
About Century Therapeutics
Century Therapeutics (IPSC) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in PHILADELPHIA, PA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1850119.
IPSC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kimberly Blackwell | Director | Jun 12, 2026 |
| Han Myung Lee | Director | Jun 12, 2026 |
| Martin Patrick Murphy | Director | Jun 12, 2026 |
| Brent Pfeiffenberger | President and CEO | Sep 15, 2026 |
| Daphne Quimi | Director | Jun 12, 2026 |
| Alessandro Riva | Director | Jun 12, 2026 |
| Joseph Truitt | Director | Sep 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Douglas Carr | SVP Finance & Operations | Sep 15, 2026 |
| Chad Cowan | Chief Scientific Officer | Jun 15, 2026 |
| Brent Pfeiffenberger | President and CEO | Sep 15, 2026 |
| Gregory Russotti | See Remarks | Sep 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 14, 2026 | Douglas Carr | Sale | 1,658 | $1.93 |
| Sep 14, 2026 | Gregory Russotti | Sale | 2,587 | $1.93 |
| Sep 8, 2026 | Gregory Russotti | Sale | 534 | $2.05 |
| Sep 8, 2026 | Douglas Carr | Sale | 254 | $2.05 |
| Aug 3, 2026 | Douglas Carr | Sale | 275 | $1.98 |
| Jun 12, 2026 | Gregory Russotti | Sale | 2,584 | $2.23 |
| Jun 12, 2026 | Douglas Carr | Sale | 1,654 | $2.23 |
| Jun 8, 2026 | Gregory Russotti | Sale | 524 | $2.11 |
| Jun 8, 2026 | Douglas Carr | Sale | 249 | $2.11 |
| May 4, 2026 | Douglas Carr | Sale | 264 | $2.34 |
| Mar 12, 2026 | Gregory Russotti | Sale | 10,076 | $2.55 |
| Mar 12, 2026 | Douglas Carr | Sale | 7,043 | $2.55 |
| Mar 9, 2026 | Douglas Carr | Sale | 247 | $2.54 |
| Mar 9, 2026 | Gregory Russotti | Sale | 479 | $2.54 |
| Feb 3, 2026 | Douglas Carr | Sale | 323 | $1.82 |
IPSC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $109.16M | $-9.58M | -0.14 | $-103.88M |
| Dec 31, 2024 | $6.59M | $-126.57M | -1.61 | $-110.14M |
| Dec 31, 2023 | $2.23M | $-136.67M | -2.30 | $-88.35M |
| Dec 31, 2022 | $5.20M | $-130.93M | -2.96 | $14.05M |
| Dec 31, 2021 | — | $-95.82M | -2.96 | $-89.00M |
Latest balance sheet: total assets $287.01M, total liabilities $54.66M, cash $49.64M (as of Jun 30, 2026).
IPSC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $1.96 |
| May 13, 2026 | 8-K Item 2.02 (results) | $2.28 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $2.50 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $0.47 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $0.55 |
| May 15, 2025 | 8-K Item 2.02 (results) | $0.52 |
| Mar 19, 2025 | 8-K Item 2.02 (results) | $0.58 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $0.97 |
| Nov 5, 2024 | 8-K Item 2.02 (results) | $1.33 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 14, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on IPSC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.